Dr.Kotlyarov

About me:

Dr. Stanislav Kotlyarov

Medical doctor, Ryazan State Medical University (2007)

PhD (2011), DSc (2024) in Health sciences (internal medicine)
I am a physician; general practitioner (family medicine)

Author of more than 100 publications

H-index in Scopus 17, in Web of Science -17

I am on the Stanford/ Elsevier Top 2% Scientists List 2024, 2025

E-mail: SKMR1@yandex.ru

Colab
Web of science

Research interests

Atherosclerosis

Biochemistry

Bioinformatics

Biomedicine

Cardiology

Diagnostics

Internal diseases

Medicinal Chemistry

Medicine

Molecular biology

Pharmacology

Pulmonology

My publications

Atherosclerosis

Molecular Pharmacology of Inflammation Resolution in Atherosclerosis

Involvement of Fatty Acids and Their Metabolites in the Development of Inflammation in Atherosclerosis

Diversity of Lipid Function in Atherogenesis: A Focus on Endothelial Mechanobiology

Role of Glycolysis and Nitric Oxide Pathway Crosstalk in Macrophages in Atherosclerosis

Involvement of Lipids and Lipid Mediators in Inflammation and Atherogenesis

Effects of Atherogenic Factors on Endothelial Cells: Bioinformatics Analysis of Differentially Expressed Genes and Signaling Pathways

Participation of Krüppel-like Factors in Atherogenesis

The Importance of the Plasma Membrane in Atherogenesis

Immunology of atherosclerosis: problems and prospects of immunotherapy

COPD

Involvement of the Innate Immune System in the Pathogenesis of Chronic Obstructive Pulmonary Disease

Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease

The Role of Inflammation in the Pathogenesis of Comorbidity of Chronic Obstructive Pulmonary Disease and Pulmonary Tuberculosis

Analysis of the Comorbid Course of Chronic Obstructive Pulmonary Disease

The Role of Multidimensional Indices for Mortality Prediction in Chronic Obstructive Pulmonary Disease

The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis

Analysis of differentially expressed genes and signaling pathways involved in atherosclerosis and chronic obstructive pulmonary disease

Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease

The Role of Inflammation in the Pathogenesis of Comorbidity of Chronic Obstructive Pulmonary Disease and Pulmonary Tuberculosis

Linking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases

Structure of Comorbidities and Causes of Death in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease

Immune Mechanisms of the Comorbid Course of Chronic Obstructive Pulmonary Disease and Tuberculosis

ABC Transporters

Clinical Significance of Lipid Transport Function of ABC Transporters in the Innate Immune System

Participation of ABCA1 Transporter in Pathogenesis of Chronic Obstructive Pulmonary Disease

The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis

Bioinformatic Analysis of ABCA1 Gene Expression in Smoking and Chronic Obstructive Pulmonary Disease

Biological Functions and Clinical Significance of the ABCG1 Transporter

Cardiology

Mechanisms of cognitive impairment in arterial hypertension

Gastroenterology

Importance of the gut microbiota in the gut-liver axis in normal and liver disease

Metabolic and immune links between sarcopenia and liver disease
Liver immunology: Biological role and clinical significance

Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease